Distributed Hypothesis Testing with Privacy Constraints

We revisit the distributed hypothesis testing (or hypothesis testing with communication constraints) problem from the viewpoint of privacy. Instead of observing the raw data directly, the transmitter observes a sanitized or randomized version of it. We impose an upper bound on the mutual information between the raw and randomized data. Under this scenario, the receiver, which is also provided with side information, is required to make a decision on whether the null or alternative hypothesis is in effect. We first provide a general lower bound on the type-II exponent for an arbitrary pair of hypotheses. Next, we show that if the distribution under the alternative hypothesis is the product of the marginals of the distribution under the null (i.e., testing against independence), then the exponent is known exactly. Moreover, we show that the strong converse property holds. Using ideas from Euclidean information theory, we also provide an approximate expression for the exponent when the communication rate is low and the privacy level is high. Finally, we illustrate our results with a binary and a Gaussian example

Is emamectin benzoate effective against the different stages of Spodoptera exigua (Hübner) (Lepidoptera, Noctuidae)?

peer-reviewedThis work was partially supported by the Spanish Ministry of Science and Innovation (project AGL 2007-66130-C03-02 to P. Medina). F. Amor and P. Bengochea acknowledge the ministry of Education and Culture and the Technical University of Madrid (UPM) for the doctoral fellowships. Special thanks to Syngenta Agro S.A. for their support.The beet armyworm, Spodoptera exigua (Hübner) (Lepidoptera, Noctuidae), is a major polyphagous pest in greenhouses and open fields worldwide and also a main problem in sweet pepper greenhouses. The effectiveness of the pesticide emamectin benzoate was tested in the laboratory on different stages of S. exigua using different concentrations and uptake routes. After dipping young (48-h-old) S. exigua eggs in emamectin benzoate at 0.5, 1 and 1.5 mg/L a.i. the chemical did not exhibit any ovicidal activity. There was, however, progressive neonate mortality at all concentrations, culminating at 72 hours after hatching, when 100% of the larvae from the treated young eggs died. Second and fourth instar S. exigua larvae did not exhibit significant mortality when exposed to the inert surfaces which were treated. In contrast, ingesting a diet contaminated with 0.5 mg/L a.i. of emamectin benzoate caused 100% mortality in L2 and L4 larvae 24 and 72 hours after ingestion, respectively. The LC50 value of the compound against L4 larvae that fed on sprayed sweet pepper leaves for 24 hours was 0.81 mg/L a.i.. When adults were fed on a solution of 0.5 mg/L a.i., there was a reduction in the female and male lifespan of 29.3% and 55.3%, respectively. Fecundity was reduced by more than 99%. These data suggest that emamectin benzoate is not only a useful insecticide when ingested by beet armyworm larvae but it also has ovolarvicidal and adult activity.Spanish Ministry of Science and Innovatio

Enxertia de maracujazeiro-amarelo (Passiflora edulis f. flavicarpa) em porta-enxertos oriundos de sementes de espécies de passifloras nativas.

Este trabalho teve como objetivo avaliar o desenvolvimento e a sobrevivência de copas de maracujazeiro-amarelo (Passiflora edulis f. flavicarpa Degener) enxertadas sobre dois porta-enxertos, oriundos de sementes de espécies de passifloras nativas. O experimento foi desenvolvido em casa de vegetal da Embrapa Mandioca e Fruticultura, no período de maio de 2012 a abril de 2013

Tres tumbas de la etapa Hispano-Goda en Gomacín, Puente la Reina (Navarra)

Se publican tres tumbas de una necrópolis inédita de la etapa visigoda (s. VIVIR d.C), descubierta en Puente la Reina, (Navarra, España). Se describe, junto a otras paleopatologías, el caso más antiguo de lepra identificado en España

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

PMCID: PMC3856490This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.PMCID: PMC385649

Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies

There is growing concern that poor experimental design and lack of transparent reporting contribute to the frequent failure of pre-clinical animal studies to translate into treatments for human disease. In 2010, the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines were introduced to help improve reporting standards. They were published in PLOS Biology and endorsed by funding agencies and publishers and their journals, including PLOS, Nature research journals, and other top-tier journals. Yet our analysis of papers published in PLOS and Nature journals indicates that there has been very little improvement in reporting standards since then. This suggests that authors, referees, and editors generally are ignoring guidelines, and the editorial endorsement is yet to be effectively implemented

Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis

PMCID: PMC379391